Anuh Pharma Limited
Anuh Pharma Limited engages in the manufacture and sale of bulk drugs and chemicals in India. It offers active pharmaceutical ingredients, including macrolides, anti-TB, anti-bacterial, anti-asthmatics, anti-diabetics, intermediates, expectorant, quinolones, anti-malarial, anti-gout, anti-biotic, anti-platelet, and antihistamines; and corticosteroids, including anti-inflammatory, immunosuppressan… Read more
Anuh Pharma Limited (ANUHPHR) - Total Liabilities
Latest total liabilities as of September 2025: ₹1.82 Billion INR
Based on the latest financial reports, Anuh Pharma Limited (ANUHPHR) has total liabilities worth ₹1.82 Billion INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Anuh Pharma Limited - Total Liabilities Trend (2022–2025)
This chart illustrates how Anuh Pharma Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Anuh Pharma Limited Competitors by Total Liabilities
The table below lists competitors of Anuh Pharma Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
tokentus investment AG
MU:14D
|
Germany | €158.49K |
|
INTRALOT (9IL.SG)
STU:9IL
|
Germany | €534.05 Million |
|
Lytone Enterprise, Inc.
TWO:1293
|
Taiwan | NT$218.22 Million |
|
Crown Baus Capital Corp
PINK:CBCA
|
USA | $262.88K |
|
Adventure Box Technology AB
ST:ADVBOX
|
Sweden | Skr15.06 Million |
Liability Composition Analysis (2022–2025)
This chart breaks down Anuh Pharma Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.11 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.56 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.36 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Anuh Pharma Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Anuh Pharma Limited (2022–2025)
The table below shows the annual total liabilities of Anuh Pharma Limited from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹1.81 Billion | +16.92% |
| 2024-03-31 | ₹1.54 Billion | -5.68% |
| 2023-03-31 | ₹1.64 Billion | +22.76% |
| 2022-03-31 | ₹1.33 Billion | -- |